Role of non-homologous end joining (NHEJ) in maintaining genomic integrity

DNA Repair

Volumn 5, Issue 9-10, 2006, Pages 1042-1048

  Burma, Sandeep ^a   Chen, Benjamin P C ^a   Chen, David J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Carcinogenesis; DNA double strand break (DSB) DNA dependent protein kinase (DNA PK); Genomic instability; Non homologous end joining (NHEJ)

Indexed keywords

ARTEMIS; BRCA1 PROTEIN; DNA DEPENDENT PROTEIN KINASE; DOUBLE STRANDED DNA; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN; UNCLASSIFIED DRUG;

B LYMPHOCYTE; CANCER; CARCINOGENESIS; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; COMBINED IMMUNODEFICIENCY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; EMBRYONIC STEM CELL; GENE FUNCTION; GENE MUTATION; GENETIC STABILITY; GENOME; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; NON HOMOLOGOUS END JOINING; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SENESCENCE; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; TUMOR SUPPRESSOR GENE;

ANIMALS; BRCA1 PROTEIN; CHROMATIN; DNA LIGASES; DNA REPAIR; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; GENOMIC INSTABILITY; HUMANS; MUTATION; NEOPLASMS; NUCLEAR PROTEINS; RECOMBINATION, GENETIC;

MAMMALIA;

EID: 33747889722     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2006.05.026     Document Type: Review

References (72)

1. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instabilities in human cancers. Nature 396 (1998) 643-649
2. Cadet J., Douki T., Gasparutto D., and Ravanat J.L. Oxidative damage to DNA: formation, measurement and biochemical features. Mutat. Res. 531 (2003) 5-23
3. Gellert M. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu. Rev. Biochem. 71 (2002) 101-132
4. Richardson C., and Jasin M. Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 405 (2000) 697-700
5. Vanasse G.J., Concannon P., and Willerford D.M. Regulated genomic instability and neoplasia in the lymphoid lineage. Blood 94 (1999) 3997-4010
6. O'Driscoll M., and Jeggo P.A. The role of double-strand break repair-insights from human genetics. Nat. Rev. Genet. 7 (2006) 45-54
7. Shiloh Y., and Kastan M.B. ATM: genome stability, neuronal development, and cancer cross paths. Adv. Cancer Res. 83 (2001) 209-254
8. Kinzler K.W., and Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386 (1997) 761-763
9. Khanna K.K., and Jackson S.P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 27 (2001) 247-254
10. Pierce A.J., Stark J.M., Araujo F.D., Moynahan M.E., Berwick M., and Jasin M. Double-strand breaks and tumorigenesis. Trends Cell Biol. 11 (2001) S52-S59
11. Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Orntoft T., Lukas J., and Bartek J. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434 (2005) 864-870
12. Gorgoulis V.G., Vassiliou L.V., Karakaidos P., Zacharatos P., Kotsinas A., Liloglou T., Venere M., Ditullio Jr. R.A., Kastrinakis N.G., Levy B., Kletsas D., Yoneta A., Herlyn M., Kittas C., and Halazonetis T.D. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434 (2005) 907-913
13. Lieber M.R., Ma Y., Pannicke U., and Schwarz K. The mechanism of vertebrate nonhomologous DNA end joining and its role in V(D)J recombination. DNA Repair (Amst) 3 (2004) 817-826
14. Thompson L.H., and Schild D. Recombinational DNA repair and human disease. Mutat. Res. 509 (2002) 49-78
15. Burma S., and Chen D.J. Role of DNA-PK in the cellular response to DNA double-strand breaks. DNA Repair (Amst) 3 (2004) 909-918
16. Smith G.C., and Jackson S.P. The DNA-dependent protein kinase. Genes Dev. 13 (1999) 916-934
17. Doherty A.J., and Jackson S.P. DNA repair: how Ku makes ends meet. Curr. Biol. 11 (2001) R920-R924
18. Walker J.R., Corpina R.A., and Goldberg J. Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature 412 (2001) 607-614
19. Kim S.T., Lim D.S., Canman C.E., and Kastan M.B. Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 274 (1999) 37538-37543
20. Cary R.B., Peterson S.R., Wang J., Bear D.G., Bradbury E.M., and Chen D.J. DNA looping by Ku and the DNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 94 (1997) 4267-4272
21. Chen B.P., Chan D.W., Kobayashi J., Burma S., Asaithamby A., Morotomi-Yano K., Botvinick E., Qin J., and Chen D.J. Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks. J. Biol. Chem. 280 (2005) 14709-14715
22. Chan D.W., Chen B.P., Prithivirajsingh S., Kurimasa A., Story M.D., Qin J., and Chen D.J. Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks. Genes Dev. 16 (2002) 2333-2338
23. Martin I.V., and MacNeill S.A. ATP-dependent DNA ligases. Genome Biol. 3 (2002) REVIEWS3005
24. Calsou P., Delteil C., Frit P., Drouet J., and Salles B. Coordinated assembly of Ku and p460 subunits of the DNA-dependent protein kinase on DNA ends is necessary for XRCC4-ligase IV recruitment. J. Mol. Biol. 326 (2003) 93-103
25. Matsumoto Y., Suzuki N., Namba N., Umeda N., Ma X.J., Morita A., Tomita M., Enomoto A., Serizawa S., Hirano K., Sakaia K., Yasuda H., and Hosoi Y. Cleavage and phosphorylation of XRCC4 protein induced by X-irradiation. FEBS Lett. 478 (2000) 67-71
26. Leber R., Wise T.W., Mizuta R., and Meek K. The XRCC4 gene product is a target for and interacts with the DNA-dependent protein kinase. J. Biol. Chem. 273 (1998) 1794-1801
27. Ma Y., Pannicke U., Schwarz K., and Lieber M.R. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 108 (2002) 781-794
28. Riballo E., Kuhne M., Rief N., Doherty A., Smith G.C., Recio M.J., Reis C., Dahm K., Fricke A., Krempler A., Parker A.R., Jackson S.P., Gennery A., Jeggo P.A., and Lobrich M. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Mol. Cell 16 (2004) 715-724
29. Ferguson D.O., Sekiguchi J.M., Chang S., Frank K.M., Gao Y., DePinho R.A., and Alt F.W. The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc. Natl. Acad. Sci. USA 97 (2000) 6630-6633
30. Karanjawala Z.E., Grawunder U., Hsieh C.L., and Lieber M.R. The nonhomologous DNA end joining pathway is important for chromosome stability in primary fibroblasts. Curr. Biol. 9 (1999) 1501-1504
31. Martin M., Genesca A., Latre L., Jaco I., Taccioli G.E., Egozcue J., Blasco M.A., Iliakis G., and Tusell L. Postreplicative joining of DNA double-strand breaks causes genomic instability in DNA-PKcs-deficient mouse embryonic fibroblasts. Cancer Res. 65 (2005) 10223-10232
32. Auckley D.H., Crowell R.E., Heaphy E.R., Stidley C.A., Lechner J.F., Gilliland F.D., and Belinsky S.A. Reduced DNA-dependent protein kinase activity is associated with lung cancer. Carcinogenesis 22 (2001) 723-727
33. Someya M., Sakata K., Matsumoto Y., Yamamoto H., Monobe M., Ikeda H., Ando K., Hosoi Y., Suzuki N., and Hareyama M. The association of DNA-dependent protein kinase activity with chromosomal instability and risk of cancer. Carcinogenesis 27 (2006) 117-122
34. Fu Y.P., Yu J.C., Cheng T.C., Lou M.A., Hsu G.C., Wu C.Y., Chen S.T., Wu H.S., Wu P.E., and Shen C.Y. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer Res. 63 (2003) 2440-2446
35. d'Adda di Fagagna F., Hande M.P., Tong W.M., Roth D., Lansdorp P.M., Wang Z.Q., and Jackson S.P. Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr. Biol. 11 (2001) 1192-1196
36. Hsu H.L., Gilley D., Galande S.A., Hande M.P., Allen B., Kim S.H., Li G.C., Campisi J., Kohwi-Shigematsu T., and Chen D.J. Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev. 14 (2000) 2807-2812
37. Gilley D., Tanaka H., Hande M.P., Kurimasa A., Li G.C., Oshimura M., and Chen D.J. DNA-PKcs is critical for telomere capping. Proc. Natl. Acad. Sci. USA 98 (2001) 15084-15088
38. Gao Y., Sun Y., Frank K.M., Dikkes P., Fujiwara Y., Seidl K.J., Sekiguchi J.M., Rathbun G.A., Swat W., Wang J., Bronson R.T., Malynn B.A., Bryans M., Zhu C., Chaudhuri J., Davidson L., Ferrini R., Stamato T., Orkin S.H., Greenberg M.E., and Alt F.W. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 95 (1998) 891-902
39. Gao Y., Ferguson D.O., Xie W., Manis J.P., Sekiguchi J., Frank K.M., Chaudhuri J., Horner J., DePinho R.A., and Alt F.W. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 404 (2000) 897-900
40. Barnes D.E., Stamp G., Rosewell I., Denzel A., and Lindahl T. Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Curr. Biol. 8 (1998) 1395-1398
41. Frank K.M., Sharpless N.E., Gao Y., Sekiguchi J.M., Ferguson D.O., Zhu C., Manis J.P., Horner J., DePinho R.A., and Alt F.W. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol. Cell 5 (2000) 993-1002
42. Sharpless N.E., Ferguson D.O., O'Hagan R.C., Castrillon D.H., Lee C., Farazi P.A., Alson S., Fleming J., Morton C.C., Frank K., Chin L., Alt F.W., and DePinho R.A. Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations, amplifications, and deletions. Mol. Cell 8 (2001) 1187-1196
43. Riballo E., Critchlow S.E., Teo S.H., Doherty A.J., Priestley A., Broughton B., Kysela B., Beamish H., Plowman N., Arlett C.F., Lehmann A.R., Jackson S.P., and Jeggo P.A. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr. Biol. 9 (1999) 699-702
44. O'Driscoll M., Cerosaletti K.M., Girard P.M., Dai Y., Stumm M., Kysela B., Hirsch B., Gennery A., Palmer S.E., Seidel J., Gatti R.A., Varon R., Oettinger M.A., Neitzel H., Jeggo P.A., and Concannon P. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol. Cell 8 (2001) 1175-1185
45. O'Driscoll M., Gennery A.R., Seidel J., Concannon P., and Jeggo P.A. An overview of three new disorders associated with genetic instability: LIG4 syndrome, RS-SCID and ATR-Seckel syndrome. DNA Repair (Amst) 3 (2004) 1227-1235
46. Roddam P.L., Rollinson S., O'Driscoll M., Jeggo P.A., Jack A., and Morgan G.J. Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination. J. Med. Genet. 39 (2002) 900-905
47. Ahnesorg P., Smith P., and Jackson S.P. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 124 (2006) 301-313
48. Buck D., Malivert L., de Chasseval R., Barraud A., Fondaneche M.C., Sanal O., Plebani A., Stephan J.L., Hufnagel M., Le Deist F., Fischer A., Durandy A., de Villartay J.P., and Revy P. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124 (2006) 287-299
49. Moshous D., Callebaut I., de Chasseval R., Corneo B., Cavazzana-Calvo M., Le Deist F., Tezcan I., Sanal O., Bertrand Y., Philippe N., Fischer A., and de Villartay J.P. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105 (2001) 177-186
50. Moshous D., Li L., Chasseval R., Philippe N., Jabado N., Cowan M.J., Fischer A., and de Villartay J.P. A new gene involved in DNA double-strand break repair and V(D)J recombination is located on human chromosome 10p. Hum. Mol. Genet. 9 (2000) 583-588
51. Rooney S., Sekiguchi J., Zhu C., Cheng H.L., Manis J., Whitlow S., DeVido J., Foy D., Chaudhuri J., Lombard D., and Alt F.W. Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice. Mol. Cell 10 (2002) 1379-1390
52. Rooney S., Alt F.W., Lombard D., Whitlow S., Eckersdorff M., Fleming J., Fugmann S., Ferguson D.O., Schatz D.G., and Sekiguchi J. Defective DNA repair and increased genomic instability in Artemis-deficient murine cells. J. Exp. Med. 197 (2003) 553-565
53. Moshous D., Callebaut I., de Chasseval R., Poinsignon C., Villey I., Fischer A., and de Villartay J.P. The V(D)J recombination/DNA repair factor artemis belongs to the metallo-beta-lactamase family and constitutes a critical developmental checkpoint of the lymphoid system. Ann. N. Y. Acad. Sci. 987 (2003) 150-157
54. Moshous D., Pannetier C., Chasseval Rd R., Deist Fl F., Cavazzana-Calvo M., Romana S., Macintyre E., Canioni D., Brousse N., Fischer A., Casanova J.L., and Villartay J.P. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J. Clin. Invest. 111 (2003) 381-387
55. Dudasova Z., and Chovanec M. Artemis, a novel guardian of the genome. Neoplasma 50 (2003) 311-318
56. Luger K., Mader A.W., Richmond R.K., Sargent D.F., and Richmond T.J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389 (1997) 251-260
57. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., and Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273 (1998) 5858-5868
58. Fernandez-Capetillo O., Lee A., Nussenzweig M., and Nussenzweig A. H2AX: the histone guardian of the genome. DNA Repair (Amst) 3 (2004) 959-967
59. Burma S., Chen B.P., Murphy M., Kurimasa A., and Chen D.J. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 276 (2001) 42462-42467
60. Downs J.A., Lowndes N.F., and Jackson S.P. A role for Saccharomyces cerevisiae histone H2A in DNA repair. Nature 408 (2000) 1001-1004
61. Thiriet C., and Hayes J.J. Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to DNA repair. Mol. Cell 18 (2005) 617-622
62. Celeste A., Difilippantonio S., Difilippantonio M.J., Fernandez-Capetillo O., Pilch D.R., Sedelnikova O.A., Eckhaus M., Ried T., Bonner W.M., and Nussenzweig A. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 114 (2003) 371-383
63. Bassing C.H., Suh H., Ferguson D.O., Chua K.F., Manis J., Eckersdorff M., Gleason M., Bronson R., Lee C., and Alt F.W. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114 (2003) 359-370
64. Durant S.T., and Nickoloff J.A. Good timing in the cell cycle for precise DNA repair by BRCA1. Cell Cycle 4 (2005) 1216-1222
65. Bau D.T., Fu Y.P., Chen S.T., Cheng T.C., Yu J.C., Wu P.E., and Shen C.Y. Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1. Cancer Res. 64 (2004) 5013-5019
66. Powell S.N., and Kachnic L.A. Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation. Oncogene 22 (2003) 5784-5791
67. Moynahan M.E., Cui T.Y., and Jasin M. Homology-directed DNA repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation. Cancer Res. 61 (2001) 4842-4850
68. Bau D.T., Mau Y.C., and Shen C.Y. The role of BRCA1 in non-homologous end-joining. Cancer Lett. (2005)
69. Zhong Q., Boyer T.G., Chen P.L., and Lee W.H. Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts. Cancer Res. 62 (2002) 3966-3970
70. Wang H.C., Chou W.C., Shieh S.Y., and Shen C.Y. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining. Cancer Res. 66 (2006) 1391-1400
71. Zhuang J., Zhang J., Willers H., Wang H., Chung J.H., van Gent D.C., Hallahan D.E., Powell S.N., and Xia F. Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining. Cancer Res. 66 (2006) 1401-1408
72. Paull T.T., Cortez D., Bowers B., Elledge S.J., and Gellert M. Direct DNA binding by Brca1. Proc. Natl. Acad. Sci. USA 98 (2001) 6086-6091